Slough, United Kingdom

Neil Gozzard



 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Inventor Profile: Neil Gozzard

Introduction

Neil Gozzard, an accomplished inventor located in Slough, GB, has made significant contributions to the field of biopharmaceuticals through his innovative work. With a total of three patents to his name, he has focused primarily on the development of antibody molecules that target specific human proteins.

Latest Patents

Gozzard's latest patents include two related inventions titled "Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13." These inventions pertain to antibody molecules that possess specificity for antigenic determinants of human IL-13. The patents not only explore the therapeutic uses of these antibody molecules but also detail the methods for their production.

Career Highlights

During his career, Neil Gozzard has worked with prominent companies in the pharmaceutical industry, including UCB Biopharma and UCB Pharma. His experiences at these companies have equipped him with valuable insights into the research and development processes essential for bringing innovative biopharmaceutical products to market.

Collaborations

Throughout his career, Gozzard has collaborated with notable individuals such as Alastair David Griffiths Lawson and Daniel John Lightwood. These partnerships have likely enriched his research endeavors and contributed to the successful development of his patented innovations.

Conclusion

In conclusion, Neil Gozzard has firmly established himself as a noteworthy inventor in the biopharmaceutical sector. His latest patents focusing on antibody molecules targeting human IL-13 highlight his commitment to advancing therapeutic solutions. With a solid foundation built through his collaborations and experiences within leading companies, Gozzard continues to be a significant contributor to medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…